Disclosed are compounds of the formula I:
wherein R
1
, R
2
, V, W, X, Y and Z are as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors, such as, for example, inflammation.
本发明涉及的化合物的式子为I:其中R1、R2、V、W、X、Y和Z如本文所定义。这些化合物可以用于治疗由
大麻素受体介导的疾病,例如炎症。